The BRAF V600E mutation is present in approximately 10–15% of sporadic colorectal cancer (CRC) [1] and is a hallmark of the serrated neoplastic pathway of CRC, where cancers develop from serrated precursor polyps [2], [3]. Here, BRAF is linked to cancer.